Stock 542771 NOVATEOR RESEARCH LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Novateor Research Laboratories Limited

Equities

542771

INE08JY01013

Personal Products

Market Closed - Bombay S.E.
Other stock markets
 06:00:59 2024-06-21 EDT 		5-day change 1st Jan Change
43.75 INR -2.67% Intraday chart for Novateor Research Laboratories Limited -2.67% +25.00%
2023 Novateor Research Laboratories Limited announced that it has received INR 8.533 million in funding CI
2023 Novateor Research Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2020 2021 2022 2023
Capitalization 1 40.56 30.26 41.09 89.43
Enterprise Value (EV) 1 35.04 26.11 38.7 95.78
P/E ratio -420 x 313 x -18.1 x 231 x
Yield - - - -
Capitalization / Revenue 10.3 x 16.1 x 5.54 x 7.1 x
EV / Revenue 8.88 x 13.9 x 5.22 x 7.6 x
EV / EBITDA 26.8 x 23.8 x 13 x 62.8 x
EV / FCF -0.91 x -8.41 x -6.04 x -17.3 x
FCF Yield -110% -11.9% -16.5% -5.78%
Price to Book 0.47 x 0.35 x 0.52 x 1.13 x
Nbr of stocks (in thousands) 4,834 4,834 4,834 4,834
Reference price 2 8.390 6.260 8.500 18.50
Announcement Date 9/4/20 9/7/21 9/7/22 9/8/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 0.874 5.134 3.947 1.878 7.419 12.6
EBITDA 1 0.517 3.933 1.307 1.098 2.988 1.524
EBIT 1 -0.168 2.978 0.3497 0.1375 2.122 0.6664
Operating Margin -19.22% 58.01% 8.86% 7.32% 28.61% 5.29%
Earnings before Tax (EBT) 1 0.017 2.952 0.2658 0.12 -2.603 0.3952
Net income 1 0.009 2.185 -0.0789 0.118 -2.284 0.3665
Net margin 1.03% 42.56% -2% 6.29% -30.79% 2.91%
EPS 2 0.0101 0.7376 -0.0200 0.0200 -0.4700 0.0800
Free Cash Flow 1 0.59 -20.23 -38.49 -3.105 -6.403 -5.538
FCF margin 67.51% -394.03% -975.22% -165.4% -86.31% -43.95%
FCF Conversion (EBITDA) 114.12% - - - - -
FCF Conversion (Net income) 6,555.56% - - - - -
Dividend per Share - - - - - -
Announcement Date 7/30/19 7/30/19 9/4/20 9/7/21 9/7/22 9/8/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 7.95 - - - - 6.35
Net Cash position 1 - 0.58 5.52 4.15 2.39 -
Leverage (Debt/EBITDA) 15.37 x - - - - 4.166 x
Free Cash Flow 1 0.59 -20.2 -38.5 -3.11 -6.4 -5.54
ROE (net income / shareholders' equity) 0.1% 8.74% -0.12% 0.14% -2.78% 0.47%
ROA (Net income/ Total Assets) -0.56% 6.05% 0.33% 0.1% 1.55% 0.49%
Assets 1 -1.601 36.12 -23.67 122 -147.3 75
Book Value Per Share 2 10.40 13.80 17.70 17.70 16.20 16.30
Cash Flow per Share 2 0.2400 0.0700 1.430 1.360 0.9800 0.4600
Capex - 19.6 0.96 0.92 - -
Capex / Sales - 381.67% 24.25% 48.79% - -
Announcement Date 7/30/19 7/30/19 9/4/20 9/7/21 9/7/22 9/8/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Personal Products

1st Jan change Capi.
NOVATEOR RESEARCH LABORATORIES LIMITED Stock Novateor Research Laboratories Limited
+25.00% 2.53M
PROCTER & GAMBLE COMPANY Stock Procter & Gamble Company
+14.27% 394B
UNILEVER PLC Stock Unilever PLC
+16.32% 140B
COLGATE-PALMOLIVE COMPANY Stock Colgate-Palmolive Company
+23.23% 80.98B
HINDUSTAN UNILEVER LIMITED Stock Hindustan Unilever Limited
-8.13% 68.49B
ESTEE LAUDER Stock Estee Lauder
-22.58% 40.83B
KENVUE INC. Stock Kenvue Inc.
-13.66% 35.71B
ESSITY AB Stock Essity AB
+9.96% 18.49B
GODREJ CONSUMER PRODUCTS LIMITED Stock Godrej Consumer Products Limited
+25.02% 16.86B
DABUR INDIA LIMITED Stock Dabur India Limited
+8.00% 12.6B
Other Personal Products
  1. Stock Market
  2. Equities
  3. 542771 Stock
  4. Financials Novateor Research Laboratories Limited